Medical therapy and botulinum toxin in dystonia.
Jankovic
J
J
Department of Neurology, Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas 77030, USA.
D018726:Anti-Dyskinesia Agents / Q000627:therapeutic use*; D001905:Botulinum Toxins / Q000627:therapeutic use*; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D004421:Dystonia / Q000188:drug therapy*; D006801:Humans
D018726:Anti-Dyskinesia Agents; D018680:Cholinergic Antagonists; D001905:Botulinum Toxins